Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
Two recombinant fowlpox viruses containing the avian influenza H5 hemaglutinin (HA) gene were evaluated for their ability to protect chickens against challenge with a highly pathogenic isolate of avian influenza virus (H5N2). Susceptible chickens were vaccinated with the parent fowlpox vaccine virus or recombinant viruses either by wing-web puncture or comb scarification. Following challenge 4 weeks later with highly pathogenic avian influenza virus, all birds vaccinated by the wing-web method were protected by both recombinants, while 50% and 70% mortality occurred in the two groups of birds vaccinated by comb scarification. Birds vaccinated with the unaltered parent fowlpox vaccine virus or unvaccinated controls experienced 90% and 100% mortality, respectively, following challenge. Hemagglutination-inhibition (HI) antibody levels were low, and agar-gel precipitin results were negative before challenge. Very high HI titers and positive precipitating antibody responses were observed in all survivors following challenge.
Beard
C W
CW
U.S. Department of Agriculture, Southeast Poultry Research Laboratory, Athens, Georgia 30605.
Schnitzlein
W M
WM
Tripathy
D N
DN
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002645:Chickens; D005587:Fowlpox virus / Q000235:genetics / Q000276:immunology*; D006385:Hemagglutination Inhibition Tests; D053125:Influenza A Virus, H5N2 Subtype; D009980:Influenza A virus / Q000276:immunology; D005585:Influenza in Birds / Q000517:prevention & control*; D011233:Precipitin Tests; D014611:Vaccination / Q000662:veterinary*; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
D000914:Antibodies, Viral; D014614:Vaccines, Synthetic; D014765:Viral Vaccines